CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 63 enrolled
Drug / intervention
multi-port VATS +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02647775
NCT02647775N/ACompleted

Hemodynamic and Inflammatory Responses in Thoracic Surgery: Hemodynamic and Inflammatory Responses Following Video-assisted Thoracoscopic Surgery

Chang Gung Memorial Hospital·interventional·Posted Jan 6, 2016·Updated Jan 22, 2020

In Brief

A clinical study evaluating multi-port VATS and single-port VATS for Video-Assisted Thoracic Surgery. Completed, enrolled 63 participants across 1 site.

Detailed Summary

Video-assisted thoracoscopic surgery (VATS) for thoracic surgery is practical, has been shown to reduce postoperative discomfort, and has improved cosmetic results when compare to open thoracotomy. The specific aims of this project are: to clarify the physiologic and immunologic effects of different approaches for minimally invasive thoracic surgery: (1) multiple-port VATS; (2) single-port VATS

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesTaiwan
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedJan 6, 2016
Enrollment StartJan 1, 2016
Primary CompletionJan 1, 2018
Study CompletionDec 1, 2018
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 10.5 years ago

Interventions

multi-port VATSprocedure

Patients with thoracic surgical diseases who underwent VATS will be recruited into this study to investigate the postoperative pain , physiologic and immunologic impacts of two different approaches for minimally invasive thoracic surgery.

single-port VATSprocedure

Patients with thoracic surgical diseases who underwent VATS will be recruited into this study to investigate the postoperative pain , physiologic and immunologic impacts of two different approaches for minimally invasive thoracic surgery.